Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists

Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists

US Patent 9567343 · Granted Feb 14, 2017

Estimated economic value: $10,868,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine recept2025
Isoquinoline derivatives for use in treating GLUT1 deficiency syndrome2024
TREM2 stabilizing antibodies2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Use of nicotinic acetylcholine receptor alpha 7 activators2021
Heterocyclic derivatives and their use in the treatment of neurological disorder2020
Use of nicotinic acetylcholine receptor alpha 7 activators2020
Heterocyclic derivatives and their use in the treatment of neurological disorder2019
Heterocyclic derivatives and their use in the treatment of neurological disorder2018
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists2017
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists2017